PTC Therapeutics, Inc.
PTCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070081
In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 11 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in PTC Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +32 vs. Q2 2022
- Shares held
- 76.3M
- +2.14M (+2.9%) vs. Q2 2022
- Total value
- $3.83B
- +$857.1M (+28.8%) vs. Q2 2022
- New holders
- 50
- 73 more added
- Sold out
- 18
- 62 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PTCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 382 | $8.20B |
| Q1 2026 | 352 | $6.51B |
| Q4 2025 | 353 | $7.04B |
| Q3 2025 | 294 | $5.07B |
| Q2 2025 | 284 | $3.90B |
| Q1 2025 | 261 | $4.02B |
| Q4 2024 | 240 | $3.51B |
| Q3 2024 | 203 | $2.93B |
| Q2 2024 | 199 | $2.44B |
| Q1 2024 | 184 | $2.48B |
| Q4 2023 | 174 | $2.33B |
| Q3 2023 | 181 | $1.83B |
| Q2 2023 | 206 | $3.30B |
| Q1 2023 | 203 | $3.81B |
| Q4 2022 | 203 | $2.94B |
| Q3 2022 | 213 | $3.83B |
| Q2 2022 | 182 | $2.97B |
| Q1 2022 | 184 | $2.76B |
| Q4 2021 | 179 | $3.00B |
| Q3 2021 | 184 | $2.77B |
| Q2 2021 | 183 | $3.13B |
| Q1 2021 | 208 | $3.52B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding PTC Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 1,467,193 | $73.7M | 0.01% | −173,793−10.6% | Reduced |
| Macquarie Group Ltd | 1,562,218 | $78.5M | 0.10% | −126,516−7.5% | Reduced |
| Loomis Sayles & Co L P | 1,618,894 | $81.3M | 0.16% | −17,941−1.1% | Reduced |
| Janus Henderson Group PLC | 2,077,864 | $104.3M | 0.08% | −57,812−2.7% | Reduced |
| Camber Capital Management LP | 2,450,000 | $123.0M | 4.11% | 00.0% | Unchanged |
| State Street Corp | 2,823,232 | $141.7M | 0.01% | −801,645−22.1% | Reduced |
| Armistice Capital, LLC | 2,900,000 | $145.6M | 3.66% | −396,000−12.0% | Reduced |
| Franklin Resources Inc | 4,468,775 | $224.3M | 0.12% | −443,035−9.0% | Reduced |
| RTW Investments, LP | 5,620,580 | $282.2M | 6.50% | +575,273+11.4% | Added |
| BlackRock Inc. | 6,108,417 | $306.6M | 0.01% | +135,795+2.3% | Added |
| Vanguard Group Inc | 7,211,720 | $362.0M | 0.01% | +28,028+0.4% | Added |
| Wellington Management Group LLP | 7,491,062 | $376.1M | 0.08% | +457,557+6.5% | Added |
| FMR LLC | 10,731,144 | $538.7M | 0.06% | +30,307+0.3% | Added |
| Walleye Capital LLC | 0 | $0 | 0.00% | −60,412−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −54,001−100.0% | Sold out |
| CM Management, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −18,495−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,214−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,002−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,427−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −8,335−100.0% | Sold out |
| Spearhead Capital Advisors, LLC | 0 | $0 | 0.00% | −7,448−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −6,845−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,589−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −2,969−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −598−100.0% | Sold out |
| MayTech Global Investments, LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |